BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16029451)

  • 1. Der(6)t(1;6)(q21-23;p21.3): a specific cytogenetic abnormality in myelofibrosis with myeloid metaplasia.
    Dingli D; Grand FH; Mahaffey V; Spurbeck J; Ross FM; Watmore AE; Reilly JT; Cross NC; Dewald GW; Tefferi A
    Br J Haematol; 2005 Jul; 130(2):229-32. PubMed ID: 16029451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic diversity among cytogenetic abnormalities in myelofibrosis with myeloid metaplasia.
    Tefferi A; Dingli D; Li CY; Dewald GW
    Cancer; 2005 Oct; 104(8):1656-60. PubMed ID: 16104040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel cytogenetic abnormality in primary myelofibrosis.
    Bae SY; Kim JS; Lee KN; Lee CK; Kim YK; Yoon SY; Lim CS; Cho YJ; Choi CW; Kim WY
    Cancer Genet Cytogenet; 2009 Oct; 194(1):65-6. PubMed ID: 19737657
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular cytogenetic analysis of complex karyotypes with derivative chromosome der(1)t(1;5) found in two patients with myeloid leukemia.
    Melichercíková J; Brezinová J; Zemanová Z; Cermák J; Michalová K
    Cancer Genet Cytogenet; 2007 Jul; 176(2):150-5. PubMed ID: 17656259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De novo appearance of der(1;7)(q10;p10) is associated with leukemic transformation and unfavorable prognosis in essential thrombocythemia.
    Hsiao HH; Ito Y; Sashida G; Ohyashiki JH; Ohyashiki K
    Leuk Res; 2005 Nov; 29(11):1247-52. PubMed ID: 16164981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of submicroscopic genetic changes and precise breakpoint mapping in myelofibrosis using high resolution mate-pair sequencing.
    Lasho T; Johnson SH; Smith DI; Crispino JD; Pardanani A; Vasmatzis G; Tefferi A
    Am J Hematol; 2013 Sep; 88(9):741-6. PubMed ID: 23733509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rearrangements of chromosome band 1p36 in non-Hodgkin's lymphoma.
    Dave BJ; Hess MM; Pickering DL; Zaleski DH; Pfeifer AL; Weisenburger DD; Armitage JO; Sanger WG
    Clin Cancer Res; 1999 Jun; 5(6):1401-9. PubMed ID: 10389925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosome aberrations including der(6)t(2;6)(p15;p21.3) and der(22)t(3;22)(p21;p11) in the evolution of essential thrombocythemia to myelofibrosis with myeloid metaplasia.
    Lazarevic V; Andersson C; Wahlin A; Golovleva I
    Cancer Genet Cytogenet; 2006 Feb; 165(1):87-9. PubMed ID: 16490605
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular cytogenetic analysis of follicular lymphoma (FL) provides detailed characterization of chromosomal instability associated with the t(14;18)(q32;q21) positive and negative subsets and histologic progression.
    Nanjangud G; Rao PH; Teruya-Feldstein J; Donnelly G; Qin J; Mehra S; Jhanwar SC; Zelenetz AD; Chaganti RS
    Cytogenet Genome Res; 2007; 118(2-4):337-44. PubMed ID: 18000388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone morphogenetic protein antagonist gene NOG is involved in myeloproliferative disease associated with myelofibrosis.
    Andrieux J; Roche-Lestienne C; Geffroy S; Desterke C; Grardel N; Plantier I; Selleslag D; Demory JL; Laï JL; Leleu X; Le Bousse-Kerdiles C; Vandenberghe P
    Cancer Genet Cytogenet; 2007 Oct; 178(1):11-6. PubMed ID: 17889703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Derivative (3)t(3;18)(q27;q21)t(18;16)(q21;?) involving the BCL2 and BCL6 genes in follicular lymphoma with t(3;14;18)(q27;q32;q21).
    Yamamoto K; Ono K; Katayama Y; Shimoyama M; Matsui T
    Cancer Genet Cytogenet; 2007 Nov; 179(1):69-75. PubMed ID: 17981218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, breakpoint distribution, and clinical correlates of t(5;12).
    Greipp PT; Dewald GW; Tefferi A
    Cancer Genet Cytogenet; 2004 Sep; 153(2):170-2. PubMed ID: 15350308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetics of agnogenic myeloid metaplasia: a study of 61 patients.
    Djordjevic V; Dencic-Fekete M; Jovanovic J; Bizic S; Jankovic G; Bogdanovic A; Cemerikic-Martinovic V; Gotic M
    Cancer Genet Cytogenet; 2007 Feb; 173(1):57-62. PubMed ID: 17284371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A marginal zone phenotype in follicular lymphoma with t(14;18) is associated with secondary cytogenetic aberrations typical of marginal zone lymphoma.
    Torlakovic EE; Aamot HV; Heim S
    J Pathol; 2006 Jun; 209(2):258-64. PubMed ID: 16583359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular genetics in chronic myeloid leukemia with variant Ph translocation].
    Wu W; Li JY; Zhu Y; Qiu HR; Pan JL; Xu W; Chen LJ; Shen YF; Xue YQ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Aug; 24(4):470-3. PubMed ID: 17680547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A der(18)t(9;18)(p13;p11) and a der(9;18)(p10;q10) in polycythemia vera associated with a hyperproliferative phenotype in transformation to postpolycythemic myelofibrosis.
    Larsen TS; Hasselbalch HC; Pallisgaard N; Kerndrup GB
    Cancer Genet Cytogenet; 2007 Jan; 172(2):107-12. PubMed ID: 17213018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulation and overexpression of HMGA2 in myelofibrosis with myeloid metaplasia.
    Andrieux J; Demory JL; Dupriez B; Quief S; Plantier I; Roumier C; Bauters F; Laï JL; Kerckaert JP
    Genes Chromosomes Cancer; 2004 Jan; 39(1):82-7. PubMed ID: 14603445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic idiopathic myelofibrosis (CIMF) resulting from a unique 3;9 translocation disrupting the janus kinase 2 (JAK2) gene.
    Mark HF; Sotomayor EA; Nelson M; Chaves F; Sanger WG; Kaleem Z; Caughron SK
    Exp Mol Pathol; 2006 Dec; 81(3):217-23. PubMed ID: 16959246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple recurrent chromosomal breakpoints in mantle cell lymphoma revealed by a combination of molecular cytogenetic techniques.
    Salaverria I; Espinet B; Carrió A; Costa D; Astier L; Slotta-Huspenina J; Quintanilla-Martinez L; Fend F; Solé F; Colomer D; Serrano S; Miró R; Beà S; Campo E
    Genes Chromosomes Cancer; 2008 Dec; 47(12):1086-97. PubMed ID: 18709664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Der(16)t(1;16)(q21;q13) as a secondary structural aberration in yet a third sarcoma, extraskeletal myxoid chondrosarcoma.
    Day SJ; Nelson M; Rosenthal H; Vergara GG; Bridge JA
    Genes Chromosomes Cancer; 1997 Dec; 20(4):425-7. PubMed ID: 9408761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.